Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENMD-2076 in Advanced/Metastatic Soft Tissue Sarcoma
NCT01719744Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jan 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enmd-2076 in soft tissue sarcoma (STS), sponsored by University Health Network. Started Jan 2013; status: completed.
02
Drugs
enmd-2076
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01719744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01719744.